Development of dual agent countermeasures to combat anthrax and plague

Ended Definitive Contract Awarded Sep 3, 2009 Last action Feb 6, 2018

Contract number: HDTRA109C0049
Awardee: Fraunhofer Usa, Inc. UEI YEKTH7PGB9L6 Part of Fraunhofer-Gesellschaft ZUR Förderung DER Angewandten Forschung Eingetragener Verein
Awarding agency: Defense Threat Reduction Agency Department of Defense
Obligated: $6,278,879

Award facts

Contract value 100% obligated: $6,278,878.68 Current and potential, with all options
Completion date 100% complete: Sep 30, 2015 Current and potential, with all options
Contracting staff: Leslie Simpson

Rachel Cole

Victor Cramer
NAICS code: 541711 Research and Development in Biotechnology
PSC: AD92 R&D- Defense Other: Other (Applied Research/Exploratory Development)
Set-aside: No set-aside
Competition: Full and Open Competition · 90 offers Negotiated Proposal / Quote
Pricing: Cost No Fee
Place of performance: Newark, DE, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Funding Only Action P00005 · Development of a vaccine for anthrax and plague.	$77,452	Feb 6, 2018
Other Administrative Action P00004	-$77,452	Oct 30, 2014
Other Administrative Action P00003 · Base period	$0	Apr 30, 2014
Supplemental Agreement for work within scope P00002 · SOW revision, base period extension	$893,269	May 6, 2013
Change Order P00001 · Base period-SOW revision and POP extension	$0	Jul 13, 2011
Original award	$5,385,609	Sep 2, 2009

HDTRA109C0049 was awarded to Fraunhofer Usa, Inc. by Defense Threat Reduction Agency (Department of Defense) on September 3, 2009.

The government has obligated $6,278,879 on HDTRA109C0049.

The extent of competition for HDTRA109C0049 was full and open competition. The government received 90 offers.

On GovTribe

Try for free Login